Researcher Portfolio

 
   

Dr. Teske, Andreas

Department of Molecular Ecology, Max Planck Institute for Marine Microbiology, Max Planck Society  

 

Researcher Profile

 
Position: Department of Molecular Ecology, Max Planck Institute for Marine Microbiology, Max Planck Society
Researcher ID: https://pure.mpg.de/cone/persons/resource/persons210814

External references

 

Publications

 
  (1 - 25 of 163)
 : Limmer, S., Hahn, J., Schmidt, R., Wachholz, K., Zengerle, A., Lechner, K., Eibl, H. J., Issels, R. D., Hossann, M., & Lindner, L. H. (2014). Gemcitabine treatment of rat soft tissue sarcoma with phosphatidyldiglycerol-based thermosensitive liposomes. Pharmaceutical Research, 31(9), 2276-2286. doi:10.1007/s11095-014-1322-6. [PubMan] : Rudner, J., Ruiner, C. E., Handrick, R., Eibl, H. J., Belka, C., & Jendrossek, V. (2010). The Akt-inhibitor Erufosine induces apoptotic cell death in prostate cancer cells and increases the short term effects of ionizing radiation. Radiation Oncology, 5: 108. [PubMan] : Hossann, M., Wang, T. T., Wiggenhorn, M., Schmidt, R., Zengerle, A., Winter, G., Eibl, H. J., Peller, M., Reiser, M., Issels, R. D., & Lindner, L. H. (2010). Size of thermosensitive liposomes influences content release. Journal of Controlled Release, 147(3), 436-443. [PubMan] : Koenigs, S. K., Pallasch, C. P., Lindner, L. H., Schwamb, J., Schulz, A., Brinker, R., Claasen, J., Veldurthy, A., Eibl, H. J., Hallek, M., & Wendtner, C. M. (2010). Erufosine, a novel alkylphosphocholine, induces apoptosis in CLL through a caspase-dependent pathway. Leukemia Research: Interdisciplinary International, 34(8), 1064-1069. [PubMan] : Martelli, A. M., Papa, V., Tazzari, P. L., Ricci, F., Evangelisti, C., Chiarini, F., Grimaldi, C., Cappellini, A., Martinelli, G., Ottaviani, E., Pagliaro, P., Horn, S., Baesecke, J., Lindner, L. H., Eibl, H. J., & McCubrey, J. A. (2010). Erucylphosphohomocholine, the first intravenously applicable alkylphosphocholine, is cytotoxic to acute myelogenous leukemia cells through JNK- and PP2A-dependent mechanisms. Leukemia: the Journal of Normal and Malignant Hemopoiese; Official Journal of the Leukemia Research Fund U.K., 24(4), 687-698. [PubMan] : Henke, G., Lindner, L. H., Vogeser, M., Eibl, H. J., Woerner, J., Mueller, A. C., Bamberg, M., Wachholz, K., Belka, C., & Jendrossek, V. (2009). Pharmacokinetics and biodistribution of Erufosine in nude mice - implications for combination with radiotherapy. Radiation Oncology, 4(1): 46. Retrieved from http://www.ro-journal.com/content/pdf/1748-717X-4-46.pdf. [PubMan] : Papa, V., Tazzari, P., Chiarini, F., Ricci, F., Martinelli, G., Bontadini, A., McCubrey, J., Lindner, L. H., Eibl, H., & Martelli, A. M. (2008). Erucylphosphohomocholine, the first intravenously applicable alkylphosphocholine, induces cell cycle arrest, apoptosis, and synergizes with chemotherapeutic drugs in acute myelogenous leukemia cells-a novel therapeutic approach for leukemia. Blood, 112(11), 480-480. [PubMan] : Fiegl, M., Lindner, L. H., Juergens, M., Eibl, H., Hiddemann, W., & Braess, J. (2008). Erufosine, a novel alkylphosphocholine, in acute myeloid leukemia: single activity and combination with other antileukemic drugs. Cancer Chemotherapy and Pharmacology, 62(2), 321-329. Retrieved from http://springerlink.metapress.com/content/v275q06mt983t646/fulltext.html. [PubMan] : Lindner, L. H., Eibl, H., Hossann, M., & Vogeser, M. (2008). Quantification of erufosine, the first intravenously applicable alkylphosphocholine, in human plasma by isotope dilution liquid chromatography–tandem mass spectrometry using a deuterated internal standard. Journal of Chromatography B, 869(1-2), 16-19. Retrieved from http://www.sciencedirect.com/science?_ob=MImg&_imagekey=B6X0P-4SGD4TF-4-9&_cdi=7220&_user=38661&_orig=browse&_coverDate=06%2F15%2F2008&_sk=991309998&view=c&wchp=dGLbVlW-zSkzk&md5=54b94e6454b46c82d33b75ee7ccd4377&ie=/sdarticle.pdf. [PubMan] : Henke, G., Lindner, L. H., Vogeser, M., Eibl, H., Woerner, J., Bamberg, M., Belka, C., & Jendrossek, V. (2008). Pharmaceutical kinetics and bio-availability of Erufosine in the nude-mouse model. Strahlentherapie und Onkologie, 184(Suppl. 1), 122-122. [PubMan] : Ruebel, A., Handrick, R., Eibl, H., Belka, C., & Jendrossek, V. (2008). The combined effect of membrane operative apoptosis modulator and radiation therapy is dependent form mitochondrial cell death path. Strahlentherapie und Onkologie, 184(Suppl. 1), 50-50. [PubMan] : Wang, T., Hossann, M., Reinl, H. M., Peller, M., Eibl, H., Reiser, M., Issels, R. D., & Lindner, L. H. (2008). In vitro characterization of phosphatidylglyceroglycerol-based thermosensitive liposomes with encapsulated H-1 MR T-1-shortening gadodiamide. Contrast Media and Molecular Imaging, 3(1), 19-26. Retrieved from http://www3.interscience.wiley.com/cgi-bin/fulltext/117928885/PDFSTART. [PubMan] : Lindner, L. H., Hossann, M., Vogeser, M., Teichert, N., Wachholz, K., Eibl, H., Hiddemann, W., & Issels, R. (2008). Dual role of hexadecylphosphocholine (miltefosine) in thermosensitive liposomes: Active ingredient and mediator of drug release. Journal of Controlled Release, 125(2), 112-120. Retrieved from http://www.sciencedirect.com/science?_ob=MImg&_imagekey=B6T3D-4PYGVMN-2-2&_cdi=4944&_user=38661&_orig=search&_coverDate=01%2F22%2F2008&_sk=998749997&view=c&wchp=dGLbVlb-zSkWA&md5=52cd26757702fe9aa22b4418487875ce&ie=/sdarticle.pdf. [PubMan] : Hossann, M., Wiggenhorn, M., Schwerdt, A., Wachholz, K., Teichert, N., Eibl, H., Issels, R. D., & Lindner, L. H. (2007). In vitro stability and content release properties of phosphatidylglyceroglycerol containing thermosensitive liposomes. Biochimica et Biophysica Acta-Biomembranes, 1768(10), 2491-2499. Retrieved from http://www.sciencedirect.com/science?_ob=MImg&_imagekey=B6T1T-4NWNCT1-1-C&_cdi=4899&_user=38661&_orig=browse&_coverDate=10%2F31%2F2007&_sk=982319989&view=c&wchp=dGLbVtz-zSkzS&md5=ab062670b347c074796defab714e9cdb&ie=/sdarticle.pdf. [PubMan] : Goebel, W., Obermeyer, N., Bleicher, N., Kratzmeier, M., Eibl, H., Doenecke, D., & Albig, W. (2007). Apoptotic DNA fragmentation is not related to the phosphorylation state of histone H1. Biological Chemistry, 388(2), 197-206. doi:10.1515/BC.2007.022. [PubMan] : Erdlenbruch, B., Preusse, A., Huelper, P., Kugler, W., Eibl, H., & Lakomek, M. (2006). Increased transfer of antibodiesto the CNS using BBB opening with 1-O-pentylglycerol and 2-O-hexyldiglycerol: Visualization of drug transfer using in vivo optical imaging. Neuro-Oncology, 8(4), 328-328. [PubMan] : Handrick, R., Ruebel, A., Faltin, H., Eibl, H., Belka, C., & Jendrossek, V. (2006). Increased cytotoxicity of ionizing radiation in combination with membrane-targeted apoptosis modulators involves downregulation of protein kinase B/Akt-mediated survival-signaling. Radiotherapy and Oncology, 80(2), 199-206. Retrieved from http://www.sciencedirect.com/science?_ob=MImg&_imagekey=B6TBY-4KNKBJK-7-9&_cdi=5155&_user=38661&_orig=browse&_coverDate=08%2F31%2F2006&_sk=999199997&view=c&wchp=dGLzVtb-zSkzV&md5=0b01e2c6afc90e49b9cfcd35098d3294&ie=/sdarticle.pdf. [PubMan] : Ruebel, A., Handrick, R., Eibl, H., Budach, W., Belka, C., & Jendrossek, V. (2006). Membrane-effective apoptosis modulators improve the radiation effect on cell lines of malignant gliomas in vitro: Influence on cell death- and survival signal paths. Strahlentherapie und Onkologie, 182(Suppl. 1), 85-85. [PubMan] : Ruebel, A., Handrick, R., Eibl, H., Budach, W., Belka, C., & Jendrossek, V. (2006). Increased cytotoxicity of ionizing radiation in combination with membrane-targeted apoptosis modulators involves downregulation of PKB/Akt-mediated survival signalling. Radiotherapy and Oncology, 78(Suppl. 1), S49-S49. [PubMan] : Lindner, L. H., Brock, R., Arndt-Jovin, D. J., & Eibl, H. (2006). Structural variation of cationic lipids: minimum requirement for improved oligonucleotide delivery into cells. Journal of Controlled Release, 110(2): 10.1016/j.jconrel.2005.10.009, pp. 444-456. Retrieved from http://www.sciencedirect.com/science?_ob=MImg&_imagekey=B6T3D-4HK5SG2-6-R&_cdi=4944&_user=38661&_orig=search&_coverDate=01%2F10%2F2006&_sk=998899997&view=c&wchp=dGLzVtb-zSkWz&md5=01be42df58bf5f0afde9239578a03c02&ie=/sdarticle.pdf. [PubMan] : Kugler, W., Buchholz, F., Koehler, F., Eibl, H., Lakomek, M., & Erdlenbruch, B. (2005). Downregulation of Apaf-1 and caspase-3 by RNA interference in human glioma cells: Consequences for erucylphosphocholine-induced apoptosis. Apoptosis, 10(5), 1163-1174. Retrieved from http://springerlink.metapress.com/content/n2gjqk5172801j11/fulltext.pdf. [PubMan] : Handrick, R., Rudner, J., Mueller, I., Eibl, H., Belka, C., & Jendrossek, V. (2005). Bcl-2 mediated inhibition of erucylphosphocholine-induced apoptosis depends on its subcellular localisation. Biochemical Pharmacology, 70(6), 837-850. Retrieved from http://www.sciencedirect.com/science?_ob=MImg&_imagekey=B6T4P-4GSTP88-1-H&_cdi=4980&_user=38661&_orig=browse&_coverDate=09%2F15%2F2005&_sk=999299993&view=c&wchp=dGLbVtz-zSkWz&md5=ae511726c6b252cc99ab43f6441f68ec&ie=/sdarticle.pdf. [PubMan] : Ruebel, A., Handrick, R., Eibl, H., Belka, C., & Jendrossek, V. (2005). Influence of erucylphosphocholin on the sensitivity of glioblastoma cell lines opposite radiation-induced apoptosis. Strahlentherapie und Onkologie, 181(Suppl. 1), 103-104. [PubMan] : Handrick, R., Rudner, J., Mueller, I., Eibl, H., Belka, C., & Jendrossek, V. (2005). Importance of sub-cellular localisation of Bcl-2 for the protective effect against erucylphosphocholin-induced apoptosis. Strahlentherapie und Onkologie, 181(Suppl. 1), 104-104. [PubMan] : Erdlenbruch, B., Kugler, W., Schinkhof, C., Neurath, H., Eibl, H., & Lakomek, M. (2005). Blood-brain barrier opening with alkylglycerols: Biodistribution of 1-O-pentylglycerol after intravenous and intracarotid administration in rats. Journal of Drug Targeting, 13(3), 143-150. Retrieved from http://www.informaworld.com/smpp/ftinterface~content=a713728741~fulltext=713240928. [PubMan]